Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0203) | |||||
---|---|---|---|---|---|
DME Name | Fatty acid desaturase 2 (FADS2), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 1.14.19.3 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2B30 Lymphoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Lymphoma | Significant hypermethylation | |||
Interaction Name | DNMT-FADS2 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 9.81E-08; delta-beta: 3.18E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the FADS2 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Fatty acid desaturase 2. As a result, the interaction between DNMT and FADS2 can significantly affect the drug-metabolizing process of Fatty acid desaturase 2. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2C12 Liver cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Histone modification | |||||
Histone acetyltransferases (HATs) | Liver cancer | Activation | |||
Uniprot ID | |||||
Interaction Name | HATs-FADS2 interaction | [1] | |||
Studied Cell Lines | HCC cell line | ||||
Description | Histone acetyltransferases (HATs) are reported to acetylate the FADS2 gene and thereby activate the transcriptional activity of the drug-metabolizing enzyme Fatty acid desaturase 2. As a result, the interaction between HATs and FADS2 can enhance the drug-metabolizing process of Fatty acid desaturase 2. | ||||
ICD-11: 2E06 Prostate cancer metastasis | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Prostate cancer metastasis | Significant hypermethylation | |||
Interaction Name | DNMT-FADS2 interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 3.22E-02; delta-beta: 3.52E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the FADS2 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Fatty acid desaturase 2. As a result, the interaction between DNMT and FADS2 can significantly affect the drug-metabolizing process of Fatty acid desaturase 2. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
References | |||||
---|---|---|---|---|---|
1 | Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis. J Virol. 2015 Jan;89(1):605-14. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.